Sai Life Sciences peers

Companies like Sai Life Scienceslatest year

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SAILIFE₹1,495.70

Sai Life Sciences Ltd.

· Pharma & Health
₹ CrorePeersSYNGENEDIVISLABPPLPHARMANHNEULANDLABNATCOPHARMLALPATHLABCOHANCEMcap ₹31,676 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
SAILIFE
FY26
SYNGENE
FY26
DIVISLAB
FY26
PPLPHARMA
FY26
Peer
Average
Valuation — at last close
P/E89.94×◆ 50.65×99.89×—75.27× +19%
P/B12.75×◆ 3.32×15.28×3.75×7.45× +71%
EV/EBITDA50.09×◆ 16.09×73.43×37.73×42.42× +18%
Market Cap₹31,676 Cr₹16,060 Cr₹2.56L Cr₹30,628 Cr₹1.01L Cr -69%
Growth
Revenue CAGR 3Y—5.40%◆ 10.78%7.79%7.99%
Revenue CAGR 5Y—◆ 11.35%8.67%—10.01%
Net Income CAGR 3Y—-11.98%◆ 12.09%—0.05%
Revenue YoY (latest Q)11.66%-8.55%27.80%◆ 28.05%15.77% -26%
Net Income YoY (latest Q)21.22%-52.01%65.50%◆ 105.07%39.52% -46%
Profitability
EBITDA Margin28.79%24.57%◆ 32.59%10.39%22.52% +28%
Net Income Margin15.91%8.47%◆ 24.32%-3.68%9.70% +64%
Return on Common Equity15.13%6.62%◆ 16.19%-4.00%6.27% +141%
Return on Capital Employed17.79%8.54%◆ 17.80%0.72%9.02% +97%
Return on Assets10.28%4.57%◆ 13.89%-1.94%5.51% +87%
Credit & Quality
Total Debt/Equity0.04×◆ 0.00×0.00×0.67×0.22× -82%
Interest Coverage11.83×9.54×◆ 129.48×0.27×46.43× -75%
Scale — latest FY
Revenue / Total Income₹2,192 Cr₹3,739 Cr₹10,560 Cr₹8,869 Cr₹7,723 Cr -72%
Net Income₹349 Cr₹317 Cr₹2,568 Cr−₹326 Cr₹853 Cr -59%
Total Assets₹3,626 Cr₹7,055 Cr₹20,033 Cr₹17,965 Cr₹15,018 Cr -76%
EPS₹16.63₹7.87₹96.75₹-2.46₹34.05 -51%
Book Value per Share₹117.28₹120.11₹632.49₹61.5₹271.37 -57%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.